These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9434856)

  • 1. The L5178Y/tk+/- mouse lymphoma specific gene and chromosomal mutation assay a phase III report of the U.S. Environmental Protection Agency Gene-Tox Program.
    Mitchell AD; Auletta AE; Clive D; Kirby PE; Moore MM; Myhr BC
    Mutat Res; 1997 Nov; 394(1-3):177-303. PubMed ID: 9434856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling the mouse lymphoma forward mutational assay: the Gene-Tox program database.
    Grant SG; Zhang YP; Klopman G; Rosenkranz HS
    Mutat Res; 2000 Feb; 465(1-2):201-29. PubMed ID: 10708987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the mouse lymphoma tk assay (microwell method) as an alternative to the in vitro chromosomal aberration test.
    Honma M; Hayashi M; Shimada H; Tanaka N; Wakuri S; Awogi T; Yamamoto KI; Kodani N; Nishi Y; Nakadate M; Sofuni T
    Mutagenesis; 1999 Jan; 14(1):5-22. PubMed ID: 10474816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific gene mutations in L5178Y cells in culture.
    Clive D; McCuen R; Spector JF; Piper C; Mavournin KH
    Mutat Res; 1983 Jun; 115(2):225-51. PubMed ID: 6855786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of the L5178Y TK+/- mouse lymphoma forward mutation assay using 42 chemicals.
    Oberly TJ; Bewsey BJ; Probst GS
    Mutat Res; 1984 Feb; 125(2):291-306. PubMed ID: 6700611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The need for long-term treatment in the mouse lymphoma assay.
    Honma M; Zhang LZ; Sakamoto H; Ozaki M; Takeshita K; Momose M; Hayashi M; Sofuni T
    Mutagenesis; 1999 Jan; 14(1):23-9. PubMed ID: 10474817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the genotoxicity of vincristine and colchicine using mouse lymphoma tk mutation assay].
    Wang YJ; Zhang LS
    Wei Sheng Yan Jiu; 2006 Mar; 35(2):179-81. PubMed ID: 16758965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of chromosome aberration frequency and small-colony TK-deficient mutant frequency in L5178Y/TK(+/-)-3.7.2C mouse lymphoma cells.
    Moore MM; Doerr CL
    Mutagenesis; 1990 Nov; 5(6):609-14. PubMed ID: 2263219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mouse lymphoma assay detects recombination, deletion, and aneuploidy.
    Wang J; Sawyer JR; Chen L; Chen T; Honma M; Mei N; Moore MM
    Toxicol Sci; 2009 May; 109(1):96-105. PubMed ID: 19237551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro Mouse Lymphoma Cell (L5178Y Tk
    Schisler MR; Moore MM; Gollapudi BB
    Methods Mol Biol; 2019; 2031():3-28. PubMed ID: 31473952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical mutagenesis at the thymidine kinase locus in L5178Y mouse lymphoma cells: results for 31 coded compounds in the National Toxicology Program.
    Myhr BC; Caspary WJ
    Environ Mol Mutagen; 1991; 18(1):51-83. PubMed ID: 1864269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and chromosomal assignment of two heterozygous mutations in the Trp53 gene in L5178Y/Tk(+/-)-3.7.2C mouse lymphoma cells.
    Clark LS; Hart DW; Vojta PJ; Harrington-Brock K; Barrett JC; Moore MM; Tindall KR
    Mutagenesis; 1998 Sep; 13(5):427-34. PubMed ID: 9800187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mouse lymphoma assay.
    Lloyd M; Kidd D
    Methods Mol Biol; 2012; 817():35-54. PubMed ID: 22147567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro mouse lymphoma (L5178Y Tk⁺/⁻-3.7.2C) forward mutation assay.
    Schisler MR; Moore MM; Gollapudi BB
    Methods Mol Biol; 2013; 1044():27-50. PubMed ID: 23896870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant frequencies and loss of heterozygosity induced by N-ethyl-N-nitrosourea in the thymidine kinase gene of L5178Y/TK(+/-)-3.7.2C mouse lymphoma cells.
    Chen T; Harrington-Brock K; Moore MM
    Mutagenesis; 2002 Mar; 17(2):105-9. PubMed ID: 11880538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Loss of Heterozygosity in Tk-Deficient Mutants from L5178Y Tk
    Guo X; Chen Y; Moore MM; Mei N
    Methods Mol Biol; 2020; 2102():251-270. PubMed ID: 31989560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A method to distinguish between the de novo induction of thymidine kinase mutants and the selection of pre-existing thymidine kinase mutants in the mouse lymphoma assay.
    Wang J; Heflich RH; Moore MM
    Mutat Res; 2007 Jan; 626(1-2):185-90. PubMed ID: 17055776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of U. S. National Toxicology Program (NTP) mouse lymphoma assay data using International Workshop on Genotoxicity Tests (IWGT) and the Organization for Economic Co-Operation and Development (OECD) criteria.
    Schisler MR; Gollapudi BB; Moore MM
    Environ Mol Mutagen; 2018 Dec; 59(9):829-841. PubMed ID: 30357906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome analysis of small and large L5178Y mouse lymphoma cell colonies: comparison of trifluorothymidine-resistant and unselected cell colonies from mutagen-treated and control cultures.
    Blazak WF; Los FJ; Rudd CJ; Caspary WJ
    Mutat Res; 1989 Oct; 224(2):197-208. PubMed ID: 2507912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution cytogenetic analysis of L5178Y TK+/- 3.7.2C cells: variation in chromosome 11 breakpoints among small-colony TK-/- mutants.
    Hozier JC; Sawyer JR; Moore MM
    Mutat Res; 1989 Oct; 214(2):195-9. PubMed ID: 2797025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.